DNLI vs DUK · rev $3.6M vs P/E 19, rev $31.74B
Denali Therapeutics Inc (DNLI) versus Duke Energy Corporation (DUK) — a side-by-side from cached financials, not a winner call.
Denali Therapeutics Inc (DNLI) is a biotechnology company listed on US.
Duke Energy Corporation (DUK) is a utilities - regulated electric company listed on NYSE.
Latest reported DNLI revenue for 2026-06-30 was $3.6M. Net income was -$256.0M. DNLI currently screens at market cap $2.11B.
Latest reported DUK revenue for 2025-12-31 was $31.74B. Net income was $4.97B. Revenue was up 5.6% from 2024-12-31 to 2025-12-31. DUK currently screens at market cap $96.46B and trailing P/E 19.0.
DNLI currently screens at market cap $2.11B. DUK currently screens at market cap $96.46B and trailing P/E 19.0.
Not investment advice. Open the DNLI and DUK stock pages for the full models.
Not investment advice.